GT Biopharma GTBP
NASDAQ GTBP
$3.72 -0.12 (-3.12%)
At close: Nov 13, 2026 · 4:00 PM EST

GT Biopharma (GTBP) Sale and Maturity of Investments (2022 - 2024)

Updated

GT Biopharma (GTBP) recorded Sale and Maturity of Investments - Total of $1,000 in Q4 2024.

Analysis

GT Biopharma (GTBP) Sale and Maturity of Investments (2022 - 2024) Analysis & Trends

For FY2024, GT Biopharma reported Sale and Maturity of Investments - Total of $12.89 million.

  • Quarterly Sale and Maturity of Investments - Total has ranged from -$1,000 in Q3 2024 to $7.86 million in Q2 2024 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$1,000 (Q3 2024), $7.86 million (Q2 2024) and $5.03 million (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 308.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 405.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - 88.00 Mn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 2.53 Bn
10 GT Biopharma 6.65 Mn -16.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1,000.00
Sep 30, 2024 -1,000.00
Jun 30, 2024 7.86 Mn
Mar 31, 2024 5.03 Mn
Mar 31, 2022 3.53 Mn
API Access

GT Biopharma Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=GTBP&period=max&api_key=YOUR_API_KEY